关注
Alan De la Rosa
Alan De la Rosa
Internal Medicine ll TTUHSC El Paso ll Mayo Clinic
在 ttuhsc.edu 的电子邮件经过验证
标题
引用次数
年份
The association between previous use of anti‐obesity medication and semaglutide weight loss outcomes
W Ghusn, S Fansa, D Anazco, E Tama, L Cifuentes, K Gala, ...
Diabetes, Obesity and Metabolism 26 (6), 2167-2175, 2024
42024
Weight loss and cardiovascular disease risk outcomes of semaglutide: a one-year multicentered study
W Ghusn, S Fansa, D Anazco, E Tama, B Nicolalde, K Gala, A De la Rosa, ...
International Journal of Obesity, 1-6, 2024
72024
Type 2 Diabetes Remission in Patients with Leptin-Melanocortin Pathway Variants after Gastric Bypass
D Anazco, W Ghusn, S Fansa, E Tama, A Campos-Martinez, L Cifuentes, ...
Obesity 31, 29-30, 2023
2023
The Individualized Metabolic Surgery Score Predicts Weight Loss in Patients with T2DM on Semaglutide
W Ghusn, S Fansa, D Anazco, E Tama, B Nicolalde, K Gala, L Cifuentes, ...
Obesity 31, 82-83, 2023
2023
A Case Report of Cytarabine-Induced Red Ear Syndrome
M Botros, A De La Rosa, S Nadella, AY Chang, SS Maharaj
Cureus 15 (11), 2023
2023
S1485 Semaglutide Outcomes in Non-Alcoholic Fatty Liver Disease: A Multi-Centered Real-World Study
W Ghusn, S Fansa, D Anazco, E Tama, B Nicolalde, K Gala, L Cifuentes, ...
Official journal of the American College of Gastroenterology| ACG 118 (10S …, 2023
2023
S1648 Cardiovascular Disease Risk Improvement With Semaglutide in Patients With Obesity: A Multi-Centered Study
W Ghusn, D Anazco, S Fansa, E Tama, A De La Rosa, B Nicolalde, ...
Official journal of the American College of Gastroenterology| ACG 118 (10S …, 2023
2023
S1632 Effect of Changes in Gastric Emptying and Low-Calorie Phenotype Tailored Diet on Weight Loss: Results From a 12-week Clinical Trial
L Cifuentes, W Ghusn, A Campos, F Feris, D Sacoto, A De la Rosa, ...
Official journal of the American College of Gastroenterology| ACG 118 (10S …, 2023
2023
The effect of heterozygous gene variants of the leptin-melanocortin pathway on weight loss following sleeve gastrectomy
F Feris, W Ghusn, A Campos, L Cifuentes, A De la Rosa, D Sacoto, ...
Obesity Surgery 33 (7), 2246-2249, 2023
22023
Uso bem-sucedido de rivaroxabana com níveis terapêuticos de antifator xa em paciente com obesidade mórbida e embolia pulmonar aguda de risco intermediário-alto
K Dah, M Porres-Aguilar, AD Rosa, S Prakash
Jornal Vascular Brasileiro 22, e20230056, 2023
2023
Successful use of rivaroxaban achieving therapeutic anti-factor xa levels in a morbidly obese patient with acute intermediate-high risk pulmonary embolism
K Dah, M Porres-Aguilar, AD Rosa, S Prakash
Jornal Vascular Brasileiro 22, e20230056, 2023
12023
Tu1920 SATIETY GLP-1 AND PYY HORMONES PLASMA CONCENTRATION IS NOT ASSOCIATED WITH M-RNA GUT MUCOSAL EXPRESSION IN DIET INDUCED OBESITY MICE
NN Mangena, A Mcrae, F Feris, A De la Rosa, A Acosta
Gastroenterology 164 (6), S-1162, 2023
2023
Mo1915 REAL-WORLD WEIGHT LOSS AND METABOLIC PARAMETERS OUTCOMES OF SEMAGLUTIDE: A 1-YEAR MULTI-SITE STUDY
W Ghusn, S Fansa, B Nicolalde, A De la Rosa, L Cifuentes, D Sacoto, ...
Gastroenterology 164 (6), S-937, 2023
2023
Mo1916 SEMAGLUTIDE WEIGHT LOSS AND METABOLIC PARAMETERS OUTCOMES IN PATIENTS AFTER BARIATRIC SURGERIES: A 1-YEAR MULTI-CENTERED STUDY
W Ghusn, S Fansa, B Nicolalde, A De la Rosa, L Cifuentes, D Sacoto, ...
Gastroenterology 164 (6), S-938, 2023
2023
327 REGULATOR OF G-PROTEIN SIGNALING AS AN ENTEROENDOCRINE-SPECIFIC TARGET FOR OBESITY TREATMENT: ALTERED RGS9 IN ENTEROENDOCRINE CELLS IMPAIRS POSTPRANDIAL GLP-1 RESPONSE AND …
A Mcrae, NN Mangena, F Feris, A De la Rosa, A Acosta
Gastroenterology 164 (6), S-56-S-57, 2023
2023
Phenotype tailored lifestyle intervention on weight loss and cardiometabolic risk factors in adults with obesity: a single-centre, non-randomised, proof-of-concept study
L Cifuentes, W Ghusn, F Feris, A Campos, D Sacoto, A De la Rosa, ...
EClinicalMedicine 58, 2023
262023
Cardiovascular risk and diseases in patients with and without leptin-melanocortin pathway variants
L Cifuentes, A Campos, D Sacoto, W Ghusn, A De la Rosa, F Feris, ...
Mayo Clinic Proceedings 98 (4), 533-540, 2023
52023
Refractory Escherichia coli pneumonia: A case report
SA Khalafi, ADLR Vaquez, F Dihowm
Cureus 15 (2), 2023
52023
Association between food intake and gastrointestinal symptoms in patients with obesity
W Ghusn, L Cifuentes, A Campos, D Sacoto, A De La Rosa, F Feris, ...
Gastro hep advances 2 (1), 121-128, 2023
52023
A comparison between weight loss outcomes with anti-obesity medications before and during Covid-19 pandemic at a tertiary weight management center
A De la Rosa, W Ghusn, D Sacoto, A Campos, L Cifuentes, F Feris, ...
Obesity Pillars 4, 100046, 2022
82022
系统目前无法执行此操作,请稍后再试。
文章 1–20